Home
Latest News
Features
Structural Heart
Profiles
Videos
Events
Supplements
Past Issues
Subscriptions
Search
Cardiovascular News
Home
Latest News
Features
Structural Heart
Profiles
Videos
Events
Supplements
Past Issues
Subscriptions
Tag: canakinumab
Phase III Novartis study shows canakinumab reduces cardiovascular risk in heart attack survivors
26th June 2017
Novartis has announced topline results from the global Phase III CANTOS study investigating the effi...
Edit with Live CSS